The recent rule change by the Trump administration that makes it easier for employers to refuse to include free contraceptive services in their health insurance plans taps into a wider debate about privileging religious and moral freedom over other interests in policy. In a recent Journal of the American Medical Association (JAMA) Viewpoint, Ronit Stahl and LDI Senior Fellow Holly Fernandez Lynch describe how policymakers have competing duties to protect religious and moral freedom (conscience) while serving other needs of people with different beliefs (access).
Reforming Medicare to protect the health of an aging and vulnerable population is a pressing policy concern. To share some perspective, Dr. Mary Naylor led a panel entitled “Shaping the Future of Medicare” at Penn LDI’s 50th Anniversary Symposium.
LDI’s 50th anniversary symposium convened a panel to elucidate key questions for the future of value frameworks—what does value mean to different stakeholders in the health care system? How should payers, doctors, and patients appraise the value of the care they receive? What does the future hold for value frameworks in the United States?
An interdisciplinary panel of experts from health care management, economics, and nursing came together at LDI’s 50th Anniversary Symposium to discuss their perspectives on how “organizational innovation” can be used to redesign health care systems and care delivery.
PolicyLab Director David Rubin and Health Policy Director Ahaviah Glaser, along with Cindy Mann, partner at Manatt and former director for Medicaid and CHIP at the Center for Medicare and Medicaid Services (CMS), and Omar Woodard, executive director of the GreenLight Fund in Philadelphia, participated in a panel that focused on bringing children into the federal health policy conversation, one in which they have largely been left out.
Moderated by Dave Grande, the session focused on ways to integrate clinical and non-clinical services, examined policies promoting health, and encouraged unique partnerships and opportunities for strategic innovation.
A recent report from the Institute for Clinical and Economic Review (ICER) calls into question the effectiveness and cost-effectiveness of abuse-deterrent formulations at both the individual patient and population levels. It finds limited evidence that these formulations have a real-world impact on opioid abuse, and its economic impact models suggest that any success comes with an eye-popping price tag.
Sen. Bernie Sanders (I., Vt.) last week released his Medicare for All vision: a single-payer health care system that would ensure coverage for all Americans. His quest comes at a time when budget-motivated Republicans are revisiting efforts to curb costs in Medicaid through spending caps. These two efforts seem worlds apart, especially to people across the country who are counting on Congress to fix the cost and coverage challenges they are facing with their health insurance.